BRAF and Langerhans cell histiocytosis: In prior studies, MAP2K1 or BRAF mutations were found in around 90% of adult LCH patients, BRAFindel in 28.8%, and BRAFV600E in only 31.5% of adults, in contrast to pediatric patients.